Možné imunologické důsledky B cílené imunoonkologické léčby

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	ossible immunology consequences of targeted B cell immunooncological therapies
Authors	HLAVÁČKOVÁ Eva KŘENOVÁ Zdenka ŠTĚRBA Jaroslav
Year of publication	2018
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Theres is an rising number of secondary antibody deficiency patients after B cell targeted therapies. The patients should be regullary monitored during and after the treatment. Prophylactic antibiotics and IVIG shoul vbe administered when indicated.
Related projects:	Patogeneze a léčba humorální imunodeficiencí Poruchy tvorby protilátek a komplementového systému